Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2010
07/01/2010US20100170004 Compositions and methods for the modification of gene expression
07/01/2010US20100169996 Methods and compositions for modulating the sirna and rna-directed-dna methylation pathways
07/01/2010US20100169994 Animal model
07/01/2010US20100169993 Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists
07/01/2010US20100169988 Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same
07/01/2010US20100169123 Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system
07/01/2010US20100169025 Methods and gene expression signature for wnt/b-catenin signaling pathway
07/01/2010US20100168455 Production of Hydroxylated Fatty Acids in Genetically Modified Plants
07/01/2010US20100168408 Compositions and methods for labeling of nucleic acid molecules
07/01/2010US20100168401 Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes
07/01/2010US20100168387 Chimeric CrylE Delta Endotoxin and Methods of Controlling Insects
07/01/2010US20100168231 Target enzyme for the treatment of acne
07/01/2010US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
07/01/2010US20100168213 Protein-coding RNA to correct mitochondrial dysfunction
07/01/2010US20100168211 Hereditary cataract status in canines based on hsf4 gene marker
07/01/2010US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator
07/01/2010US20100168152 Fat regulation
07/01/2010US20100168135 Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel Fragment
07/01/2010US20100168118 Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin
07/01/2010US20100168114 Invertebrate acetylcholinesterase inhibitors
07/01/2010US20100168094 Modulators of cystic fibrosis transmembrane conductance regulator
07/01/2010US20100168089 Utilization of tace inhibitors for the treatment of acne
07/01/2010US20100168067 Biomarkers for bisphosphonate-responsive bone disorders
07/01/2010US20100168051 Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress
07/01/2010US20100168047 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
07/01/2010US20100168038 Use of compounds in combination with gamma-irradiation for the treatment of cancer
07/01/2010US20100168031 Lat peptides and their use in assays for identifying immunosuppressants
07/01/2010US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
07/01/2010US20100168022 Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
07/01/2010US20100168014 Screening method
07/01/2010US20100168008 Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions
07/01/2010US20100168006 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins
07/01/2010US20100167999 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps
07/01/2010US20100167993 Compounds for Enhancing p21 Expression and Methods of Use Thereof
07/01/2010US20100167960 Methods and apparatus for screening and detecting multiple genetic mutations
07/01/2010US20100167948 MicroRNA Expression Profiling of Cerebrospinal Fluid
07/01/2010US20100167947 Polymorphisms in Genes Affecting Ace-Related Disorders and Uses Thereof
07/01/2010US20100167945 Drug selection for breast cancer therapy using antibody-based arrays
07/01/2010US20100167944 Compositions and Methods for the Detection of Topoisomerase II Complexes with DNA
07/01/2010US20100167942 Compositions, Methods and Related Uses for Cleaving Modified DNA
07/01/2010US20100167941 Particle based assay system
07/01/2010US20100167940 Methods for identifying cancer risk
07/01/2010US20100167939 Multigene assay to predict outcome in an individual with glioblastoma
07/01/2010US20100167937 Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum
07/01/2010US20100167354 Methods and compositions for amplification of rna sequences
07/01/2010US20100167345 Halohydrin dehalogenases and related polynucleotides
07/01/2010US20100167340 Method to produce a receptor chip using biotinylated protein
07/01/2010US20100167337 Device for cell separation and analysis and method of using
07/01/2010US20100167336 Parameter for x- and y- chromosome bearing sperm sorting with high degree of purity
07/01/2010US20100167335 Methods for diagnosing and treating allergies
07/01/2010US20100167334 Systems and methods for processing tissue samples for histopathology
07/01/2010US20100167333 Heavy Metal Binding Compounds and Their Method of Use
07/01/2010US20100167332 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
07/01/2010US20100167331 Assessing risk of cardiac intervention in patients suffering from stable coronary heart disease based on gdf-15
07/01/2010US20100167330 Micromechanical devices for control of cell-cell interaction, and methods of use thereof
07/01/2010US20100167329 Device for drug screening
07/01/2010US20100167328 Blood cell separation
07/01/2010US20100167327 System for obfuscating identity
07/01/2010US20100167326 Method for cleavage of peptidic bond at c terminal of peptide and a method for determination of c terminal amino acid sequence of peptide
07/01/2010US20100167325 Methods for detecting risk of fatal prostate cancer using serum calcium
07/01/2010US20100167324 Quantitative Assays for Ras p21 in Body Fluids
07/01/2010US20100167322 Method of detecting cerebral stroke or asymptomatic cerebral infarction using acrolein, interleukin-6 and crp contents, polyamine oxidase activity or polyamine oxidase protein content and subject's age as indicators
07/01/2010US20100167321 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
07/01/2010US20100167320 Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States
07/01/2010US20100167306 Rapid test for glycated albumin in saliva
07/01/2010US20100167305 Methods of Detecting Mutations Associated With Ataxia-Ocular Apraxia 2 (AOA2)
07/01/2010US20100167304 Variable valve apparatus and methods
07/01/2010US20100167303 Sequences diagnostic for shrimp pathogens
07/01/2010US20100167302 Method for predicting the response of a subject suffering from a viral infection of the liver to an antiviral therapy
07/01/2010US20100167301 Method and device for immunoassay using nucleotide conjugates
07/01/2010US20100167300 MICROENVIRONMENT NICHE ASSAY FOR CiPS SCREENING
07/01/2010US20100167299 Phospholink nucleotides for sequencing applications
07/01/2010US20100167298 PURO-DHFR Quadrifunctional Marker and its use in Protein Production
07/01/2010US20100167297 Method of determining the time to progression of non small cell lung cancer after chemotherapy based on thioredoxin expression
07/01/2010US20100167296 Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expression
07/01/2010US20100167295 Methods for haplotyping genomic dna
07/01/2010US20100167294 Methods for detecting nucleic acids in a sample
07/01/2010US20100167293 Digital Assay
07/01/2010US20100167292 High fidelity polymerases and uses thereof
07/01/2010US20100167291 Assessing expression of endogenous and exogenous genes
07/01/2010US20100167290 Molecule attachment to nanoparticles
07/01/2010US20100167289 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
07/01/2010US20100167288 Methods and Compositions Related to Continuous Flow Thermal Gradient PCR
07/01/2010US20100167287 Crude biological derivatives competent for nucleic acid detection
07/01/2010US20100167286 Pluripotent cell lines and methods of use thereof
07/01/2010US20100167285 Methods and agents for evaluating inflammatory bowel disease, and targets for treatment
07/01/2010US20100167284 Nucleic acid size detection method
07/01/2010US20100167283 Analyte Detection
07/01/2010US20100167282 Lateral-flow device and method to enhance detection signal for charged molecular targets
07/01/2010US20100167281 Sequence analysis method
07/01/2010US20100167280 Oligonucleotides for discriminating related nucleic acid sequences
07/01/2010US20100167279 Unsymmetrical cyanine dyes for high resolution nucleic acid melting analysis
07/01/2010US20100167278 Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer
07/01/2010US20100167277 Fret sequencing by DNA scanning proteins
07/01/2010US20100167276 High-throughput methods for quantifying cells in environmental and laboratory samples
07/01/2010US20100167275 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels
07/01/2010US20100167274 Methods and kits for identifying nucleic acid sequences
07/01/2010US20100167273 Method for Selectively Quantifying Vegf Isoforms in a Biological Sample and Uses Thereof
07/01/2010US20100167272 Method for Detecting and Analyzing Pathogens in a Sample
07/01/2010US20100167271 Method for screening blood using a preservative that may be in a substantially solid state form